OR WAIT null SECS
February 01, 2022
CDMOs need to consistently demonstrate agility as demand increases for newly developed therapeutic modalities.
CDMOs offer expertise and customization options for sponsors of orphan drugs.
January 18, 2022
In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.
November 19, 2021
Sterling Pharma Solutions has announced a £10 million (US$13.5 million) investment into process development and manufacturing capacity at its site in Dudley, UK.
November 03, 2021
Investing in formulation strategies earlier on in development will maximize the chance of success.
August 03, 2021
Dosage form priorities are shifting to focus on user-friendliness, leading to greater engagement with outsourcing partners earlier in development timelines.
August 02, 2021
Collaborative partnerships can foster success in formulation development projects.
August 01, 2021
The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.
The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.
June 24, 2021
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.